References
- Samanta A, Chandra J, Kaur R, Anand R, Shukla S, Mandal P. Clinical profile and microbiologic spectrum of febrile neutropenic episodes in children with severe aplastic anemia. J Pediatr Hematol Oncol. 2020;42(3):193–197. doi:10.1097/MPH.0000000000001631.
- Lalaoui R, Javelle E, Bakour S, Ubeda C, Rolain JM. Infections due to carbapenem-resistant bacteria in patients with hematologic malignancies. Front Microbiol. 2020;11:1422.
- Tofas P, Skiada A, Angelopoulou M, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: analysis of 50 cases. Int J Antimicrob Agents. 2016;47(4):335–339. Aprdoi:10.1016/j.ijantimicag.2016.01.011.
- Jaiswal SR, Gupta S, Kumar RS, et al. Gut colonization with carbapenem-resistant Enterobacteriaceae adversely impacts the outcome in patients with hematological malignancies: results of a prospective surveillance study. Mediterr J Hematol Infect Dis. 2018;10:1–8.
- Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017;129(11):1428–1436. doi:10.1182/blood-2016-08-693481.
- Samarasinghe S, Veys P, Vora A, Wynn R. Paediatric amendment to adult BSH guidelines for aplastic anaemia. Br J Haematol. 2018;180(2):201–205. doi:10.1111/bjh.15066.
- Mikulska M, Raiola AM, Galaverna F, et al. Pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation: impact of T cell-replete transplantation from a haploidentical donor. Biol Blood Marrow Transplant. 2018;24(1):109–118. doi:10.1016/j.bbmt.2017.08.024.
- Camitta BM, Rappeport JM, Parkman R, Nathan DG. Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood. 1975;45(3):355–363.
- Valentini CG, Farina F, Pagano L, Teofili L. Granulocyte transfusions: a critical reappraisal. Biol Blood Marrow Transplant. 2017;23(12):2034–2041. doi:10.1016/j.bbmt.2017.07.029.
- Tumino M, Mainardi C, Pillon M, et al. Haploidentical TCR A/B and B-cell depleted hematopoietic SCT in pediatric SAA and aspergillosis. Bone Marrow Transplant. 2014;49(6):847–849. doi:10.1038/bmt.2014.58.
- Kim H, Im HJ, Koh KN, et al. Comparable outcome with a faster engraftment of optimized haploidentical hematopoietic stem cell transplantation compared with transplantations from other donor types in pediatric acquired aplastic anemia. Biol Blood Marrow Transplant. 2019;25(5):965–974. doi:10.1016/j.bbmt.2019.01.010.
- Zama D, Biagi E, Masetti R, et al. Gut microbiota and hematopoietic stem cell transplantation: where do we stand? Bone Marrow Transplant. 2017;52(1):7–14. doi:10.1038/bmt.2016.173.
- Junghanss C, Marr KA, Carter RA, et al. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant. 2002;8(9):512–520. doi:10.1053/bbmt.2002.v8.pm12374456.
- Bacigalupo A, Giammarco S. Haploidentical donor transplants for severe aplastic anemia. Semin Hematol. 2019;56(3):190–193. doi:10.1053/j.seminhematol.2019.03.004.